---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-047098"
form_type: "8-K/A"
ticker: "SKIN"
cik: "0001818093"
company_name: "SkinHealth Systems Inc."
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T02:08:33.554746+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Beauty Health terminates CRO Daniel Watson without cause; $430K severance, RSU acceleration

## Summary
- Chief Revenue Officer Daniel Watson terminated without cause effective Oct 14, 2024; advisory role through Jan 1, 2025.
- Receives $430K cash severance over 12 months, plus accelerated vesting of 329,251 RSUs.
- Will serve as consultant Jan-Mar 2025 at $40K/month; non-compete through March 2026.
- Separation Agreement filed; Watson releases all claims against the company.

## SEC filing metadata
- accession: 0001628280-24-047098
- form_type: 8-K/A
- ticker: SKIN
- cik: 0001818093
- company_name: SkinHealth Systems Inc.
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818093/000162828024047098/0001628280-24-047098-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818093/000162828024047098/skin-20241008.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-047098
- JSON: https://secwatch.observer/filing/0001628280-24-047098.json
- Plain text: https://secwatch.observer/filing/0001628280-24-047098.txt

## Key facts
- Executive change
  Daniel Watson was terminated as Chief Revenue Officer at SkinHealth Systems Inc..
  - Action: terminated
  - Role: Chief Revenue Officer
  source text: On October 8, 2024, the Board of Directors of the Company terminated Daniel Watson’s employment as Chief Revenue Officer of the Company without cause, effective as of October 14, 2024 (the "Termination Date").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000162828024047098/0001628280-24-047098-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.